EVOTAZ

This brand name is authorized in Austria, Australia, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug EVOTAZ contains a combination of these active pharmaceutical ingredients (APIs):

1 Atazanavir UNII 4MT4VIE29P - ATAZANAVIR SULFATE

Atazanavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag-Pol proteins in HIV-1 infected cells, thus preventing formation of mature virions and infection of other cells. Read about Atazanavir

2 Cobicistat UNII LW2E03M5PG - COBICISTAT

Cobicistat is a mechanism-based inhibitor of cytochromes P450 of the CYP3A subfamily. Inhibition of CYP3A-mediated metabolism by cobicistat enhances the systemic exposure of CYP3A substrates, such as darunavir, where bioavailability is limited and half-life is shortened due to CYP3A-dependent metabolism. Read about Cobicistat

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AR15		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AR Antivirals for treatment of HIV infections, combinations
Discover more medicines within J05AR15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10692R
Country: EE	Ravimiamet	Identifier(s): 1692918, 1692929
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1151025001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 455094
Country: FR	Base de données publique des médicaments	Identifier(s): 66190162
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 302259
Country: IT	Agenzia del Farmaco	Identifier(s): 044318018, 044318020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1077588, 1077589
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100345078
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61949001, W61949002
Country: US	FDA, National Drug Code	Identifier(s): 0003-3641